Sugi Predict

Sugi Predict / Compounds / SCHEMBL565885

SCHEMBL565885

SCHEMBL565885

C=CCNc1cc(-c2ccc(Oc3ccc(-c4ccc(O)c(NCC=C)c4)cc3)cc2)ccc1O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRA1 P14867 1/20 0.40
▸ GABRB2 P47870 1/20 0.40
▸ GAA P10253 4/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ GLA P06280 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ HDAC1 Q13547 7/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ APOBEC3A P31941 1/20 0.35
▸ GFER P55789 1/20 0.35
▸ APOBEC3G Q9HC16 1/20 0.35
▸ MAPT P10636 2/20 0.34
▸ XDH P47989 1/20 0.34
▸ HDAC2 Q92769 1/20 0.34
▸ HCAR3 P49019 1/20 0.33
▸ CA12 O43570 2/20 0.32
▸ CA1 P00915 2/20 0.32
▸ CA2 P00918 2/20 0.32
▸ CA9 Q16790 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL566048 0.89 GABRA1 (0.48) GABRA1GABRB2GAARAB9ASMN1; SMN2
SCHEMBL565803 0.88 GAA (0.37) GABRA1GABRB2GAARAB9ASMN1; SMN2
SCHEMBL564433 0.86 ALOX5 (0.46) GABRA1GABRB2GAAHDAC1KDM4E
SCHEMBL565589 0.85 GABRA1 (0.40) GABRA1GABRB2GAAHDAC1KDM4E
SCHEMBL566190 0.84 GAA (0.48) GAARAB9ASMN1; SMN2GLAHTT
SCHEMBL566211 0.84 CA1 (0.43) GAARAB9ASMN1; SMN2GLAHTT
Ether SCHEMBL565588 0.82 GABRA1 (0.40) GABRA1GABRB2GAARAB9ASMN1; SMN2
Ether SCHEMBL565884 0.80 ALOX5 (0.38) GABRA1GABRB2GAAHDAC1KDM4E
SCHEMBL565445 0.79 HSD17B1 (0.47) GABRA1GABRB2HDAC1KDM4EAPOBEC3A
SCHEMBL566055 0.77 CA12 (0.37) GAARAB9ASMN1; SMN2GLAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8674029-B2 Method of preparing stabilized polymeric systems using polymeric peroxides Sunocs LLC (US) 2014-03-18 — — US disclosed
US-20120035307-A1 PROCESS FOR MAKING STABLIZED POLYMERIC SYSTEMS WITH NANOSTRUCTURES SONG CHENGQIAN (US) 2012-02-09 — — US disclosed
US-20120035315-A1 METHOD OF PREPARING STABLIZED POLYMERIC SYSTEMS USING POLYMERIC PEROXIDES SONG CHENGQIAN (US) 2012-02-09 — — US disclosed
US-7498467-B2 Antioxidant and bisaminophenol derivative IDEMITSU KOSAN CO., LTD. (JP) 2009-03-03 — — US disclosed
US-20080161608-A1 ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE IDEMITSU KOSAN CO., LTD. (JP) 2008-07-03 — — US disclosed
US-20060208227-A1 Antioxidant and bisaminophenol derivative IDEMITSU LOSAN CO., LTD (JP) 2006-09-21 — — US disclosed
EP-1612254-A1 ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE IDEMITSU KOSAN COMPANY LIMITED (JP) 2006-01-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161608-A1 ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE CBR1, CBR3, HMOX1 GABRA1 1019/4885GABRB2 1083/4885GAA 3993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.